Several manufacturers report Tamiflu shortage as flu season reaches high point

As the flu season continues to rage, with the CDC reporting over 23,000 hospitalizations for influenza, several manufacturers have reported shortages of a medicine that can be used to counter it.

The American Society of Health-System Pharmacists (ASHP) reported a shortage of oseltamivir, otherwise known as Tamiflu, in several doses by five generic manufacturers. Amneal and Camber have reported a shortage in the 30 mg, 45 mg and 75 mg doses, while Macleods is reporting a shortage only in the 30 mg and 75 mg amounts. Teva and Zydus are listing a shortage of oral powder in the 60 mL bottle amount.

A reason for the shortages was not listed by the ASHP, but there are still doses available from other producers including Genentech, Ajanta, Alvogen and Strides Pharma. A hard date for when the supply will return to normal was not…
Click here to view original post